GALT

Galectin Therapeutics Inc

Jun 05 • 04:00PM ET

2.33

-0.05 -2.10 %

Healthcare • Biotechnology • USA • Micro • NASD

Peers: AGEN CNTB IMUX KZIA SPRO VRCA MOLN HURA ORMP PLX

| Held by: VTI VXF IWC MEDX QQQS

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.41	Insider Own	28.75%	Shs Outstand	65.86M	Perf Week	-7.54%
Market Cap	153.45M	Forward P/E	-	EPS next Y	-0.33	Insider Trans	-2.53%	Shs Float	46.93M	Perf Month	3.56%
Enterprise Value	277.26M	PEG	-	EPS next Q	-0.09	Inst Own	21.14%	Short Float	15.68%	Perf Quarter	-24.84%
Income	-26.44M	P/S	-	EPS this Y	22.92%	Inst Trans	6.15%	Short Ratio	21.43	Perf Half Y	-59.12%
Sales	0.00M	P/B	-	EPS next Y	10.81%	ROA	-207.62%	Short Interest	7.36M	Perf YTD	-43.99%
Book/sh	-2.01	P/C	10.88	EPS next 5Y	-	ROE	-	52W High	7.13 -67.32%	Perf Year	79.23%
Cash/sh	0.21	P/FCF	-	EPS past 3/5Y	9.53% -3.21%	ROIC	-479.65%	52W Low	1.27 83.46%	Perf 3Y	51.30%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	6.83% 8.80%	Perf 5Y	-39.48%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	43.38%	Oper. Margin	-	ATR (14)	0.20	Perf 10Y	61.79%
Dividend Ex-Date	-	Quick Ratio	2.15	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	46.93	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	2.15	EPS Q/Q	49.34%	SMA20	-1.85%	Beta	0.52	Target Price	11.00
Payout	-	Debt/Eq	-	Sales Q/Q	-	SMA50	-2.54%	Rel Volume	0.62	Prev Close	2.38
Employees	9	LT Debt/Eq	-	Earnings	May 15 BMO	SMA200	-38.92%	Avg Volume	343.49K	Price	2.33
IPO	Sep 04, 2002	Option/Short	Yes / No	EPS/Sales Surpr.	-33.33% -	Trades		Volume	215,793	Change	-2.10%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)